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The normal vestibular system may be adversely affected by environmental 
challenges which have characteristics that are unfamiliar or ambiguous in the 
patterns of sensory stimulation they provide. A disordered vestibular system lends 
susceptibility even to quotidian environmental experiences as the sufferer becomes 
dependent on potentially misleading, non-vestibular sensory stimuli. In both cases 
the sequela may be dizziness, incoordination, imbalance and unpleasant autonomic 
responses. Many forms of visual environmental motion, particularly busy places such 
as supermarkets, readily induce inappropriate sensations of sway or motion and 
imbalance referred to as visual vertigo.  All people with intact vestibular function can 
become motion sick although individual susceptibility varies widely and is partially 
determined by inheritance. Motorists learn to interpret sensory stimuli in the context 
of the car stabilised by its suspension and guided by steering.  A type of motorist 
disorientation occurs in some individuals that develop a heightened awareness of 
false perceptions of car orientation, readily experiencing stereotypical symptoms of 
threatened rolling over on corners and veering on open highways or in streaming  
traffic. This article discusses the putative mechanisms, consequences and approach 
to managing patients with visual vertigo, motion sickness and motorist disorientation 






     The vestibular apparatus is the prime, indeed only organ evolved specifically to 
signal orientation in space. It is therefore, unsurprising, that unusual, non-
physiological stimulation and disorders of vestibular function give rise to a variety of 
symptoms ranging from vertigo, through imbalance and in-co-ordination to 
autonomic distress. The interpretation, corroboration and calibration of vestibular 
signals is dependent on environmental context; importantly visual and 
somatosensory cues to orientation. Consequently, challenging visual and 
mechanical motion in the environment may have adverse effects on vestibular 
function producing dizziness and visual disorientation.  
Visual Vertigo 
     Panoramic visual motion normally accompanies head movement giving rise to 
visual motion signals which calibrate and help interpret vestibular signals of head 
movement and orientation. In normal subjects visual motion alone may occasionally 
induce sensations of self-motion, ‘vection’, as in the ‘railway train’ illusion.  However, 
as a means of compensation, some patients with vestibular disease develop an 
overreliance on environmental visual cues leading to ‘visual dependency’.  This is a 
characteristic also found in people with a certain psychological susceptibility. Visual 
vertigo may itself become a major, disabling symptom, particularly when part of the 
functional (i.e., non-organic) syndrome of PPPD (persistent perceptual postural 
dizziness).    
     Visual vertigo is an inappropriate response to motion of the visual environment 
due to overreliance or misinterpretation of visual cues due to a sensory (vestibular) 
disturbance or functional disorder.  Finally, although vehicle control becomes an 
overlearned skill, dis-adaptation in certain individuals renders them susceptible to the 
4 
 
instability of the driving environment causing a ‘motorists disorientation’ with 
components of both motion sickness and visual vertigo. 
Interaction of vestibular and visual mechanisms 
     The vestibular and visual systems complement each other in eliciting slow phase 
eye movements in order to stabilise visual images on the retina.  Pursuit-optokinetic 
eye movements are elicited by visual motion whereas vestibular eye movements 
(vestibulo-ocular reflex, VOR) are elicited by head motion.  These two systems work 
synergistically when a person rotates with eyes open while gazing at the surrounding 
environment, for instance a passenger looking out of a bus which is turning (Figure 
1).  However, they are said to be in conflict (‘visuo-vestibular conflict’) when a person 
looks at a visual object that rotates with him/her, e.g. a passenger reading a book on 
a bus.  In this case, instead of collaborating with the VOR, the visual input actually 
suppresses the VOR (VOR suppression). 
     The interaction between vestibular and visual inputs is not only present in 
physiological circumstances.  Indeed, the first line of defence against a pathological 
nystagmus due to a labyrinthine lesion is to resort to VOR suppression mechanisms 
so that visual stability can be partly restored (Figure 2).  Similarly, where there is 
absent (1) or altered visual input as in congenital nystagmus (2) or when there is 
external ophthalmoplegia (3), vestibular function and perception is modified.  It is 
thus not surprising that vestibular lesions can cause visual symptoms and that visual 
input influences vestibular symptoms.   
Clinical picture of visual vertigo 
     Many patients with a current or previous vestibular disorder report worsening or 
triggering of dizziness and imbalance in certain visual environments.  These patients 
dislike moving visual surroundings, as encountered in traffic, crowds, disco lights and 
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car-chase scenes in films.  Typically, such symptoms develop when in busy visual 
surroundings such as supermarket aisles.  The development of these symptoms in 
some patients with vestibular disorders has long been recognised (4,5,6) and given 
various names such as Visuo-Vestibular Mismatch (7,8) or Visual Vertigo (9,10).  
This syndrome should not be confused with oscillopsia.  Oscillopsia is a visual 
perception of movement, bouncing or oscillation of the visual percept. In visual 
vertigo, the trigger is visual commotion but the symptom is of a vestibular kind such 
as dizziness, vertigo, disorientation and unsteadiness.  
     The symptoms of visual vertigo frequently develop after a vestibular insult.  Any 
vestibular disorder, peripheral or central, can lead to visual vertigo but patients with 
migraine, particularly vestibular migraine, are extremely prone to developing visual 
vertigo.  A typical patient is a previously asymptomatic person who suffers an acute 
peripheral disorder (e.g. vestibular neuritis) and that after an initial period of recovery 
of a few weeks, he/she discovers that the dizzy symptoms do not fully disappear.  
Furthermore, symptoms are aggravated by looking at moving or repetitive images, 
as described above.  Patients may also develop anxiety or frustration because 
symptoms do not go away or because medical practitioners tend to disregard them.   
     The origin and significance of the symptoms of visual vertigo in vestibular patients 
has been the subject of research.  We know that tilted or moving visual surroundings 
have a pronounced influence on these patients’ perception of verticality and balance, 
over and above what can be expected from an underlying vestibular deficit (9,10).  
This increased responsiveness to visual stimuli is called ‘visual dependency’.  
Patients with central vestibular disorders and patients combining vestibular disorders 
and congenital squints or squint surgery can also report visual vertigo and show 
enhanced visuo-postural reactivity (9).   
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     Overall, these findings suggest that the combination of a vestibular disorder and 
visual dependence in a given patient is what leads to the visual vertigo syndrome.  
Ultimately, what makes some patients with vestibular disorders develop such visual 
dependence is not known.  The role of the associated anxiety-depression, often 
observed in these patients, and whether this is a primary or secondary phenomenon 
is not clear.  Earlier evidence indicated that anxiety or depression levels were not 
higher in visual vertigo patients than in other patients seen in dizziness clinics 
(10,11).  Recently, however, a longitudinal study of unselected patients with acute 
vestibular neuritis showed that the grouping of visual dependence, psychological 
dysfunction (anxiety, depression, somatization traits) and autonomic arousal in a 
single statistical factor was able to predict long term symptoms and handicap (12).  
So this work does suggest an interrelation between long term vestibular symptoms, 
psychological symptoms and visual vertigo. 
     The more important differential diagnosis in a patient presenting to clinic with 
visual vertigo is, however, one of a purely psychological disorder or panic attacks 
(13).  Neurologists or neuro-otologists are usually happy to treat a patient with visual 
vertigo as a secondary complication of vestibular disease but not necessarily so if 
the patient’s presentation appears primarily as psychiatric.  An accepted set of 
criteria to distinguish between psychological and vestibular symptoms is not 
completely agreed presently (13,14,15), although the delineation of PPPD as a 
functional vestibular syndrome has been a major practical development in neuro-
otology (see below).  In principle, however, a patient who has never had a clear 
history of vestibular disease, with no findings on vestibular examination and with 
visual triggers restricted to a single particular environment (e.g. a specific 
supermarket) would be more likely to have a primary psychological disorder.  
7 
 
Reciprocally, a patient with no pre-morbid features of psychological dysfunction who 
after a vestibular insult may develop car tilting illusions when driving (16) or dizziness 
when looking at various moving visual scenes (traffic, crowds, movies) is more likely 
to have the visual vertigo syndrome.   
     The syndrome of persistent perceptual postural dizziness (PPPD or 3PD), which 
is exceedingly common in specialist clinics, has been recently defined and diagnostic 
criteria have been proposed (17).  In summary, patients report dizziness, 
unsteadiness, or non-spinning vertigo on most days for prolonged periods of time, 
but may wax and wane in severity.   Persistent symptoms occur without specific 
provocation, but are often exacerbated by upright posture, active or passive motion, 
moving visual stimuli or complex visual patterns.  The disorder is triggered by events 
that cause vertigo, unsteadiness, dizziness, or problems with balance including 
acute, episodic, or chronic vestibular syndromes, other neurologic or medical 
illnesses, and psychological distress.  It can be seen that visual vertigo, as discussed 
in the preceding paragraphs, can feature in patients with PPPD but visual vertigo can 
exist without PPPD and, vice versa, PPPD can exist without visual vertigo.   
Treatment of visual vertigo 
     There are three aspects in the treatment of patients with the visual vertigo 
syndrome.  The first is specific measures for the underlying vestibular disorder, e.g. 
Meniere’s disease, BPPV, migraine, but discussing these is beyond the scope of this 
article.  However, given that a specific etiological diagnosis cannot be confirmed in 
many patients with chronic dizziness symptomatic treatment as discussed below 
should not be delayed.   
     Secondly, patients benefit from general vestibular rehabilitation with a suitably 
trained audiologist or physiotherapist. These exercise-based programs can be either 
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generic, like the original Cawthorne-Cooksey approach (18) or, preferably, 
customised to the patient’s needs.  All regimes involve progressive eye, head and 
whole body movements (bending, turning) as well as walking exercises (19, 20, 21). 
     Finally, specific measures should be introduced in the rehabilitation program for 
visual vertigo patients in order to reduce their hyper-sensitivity to visual motion.  The 
aim is to promote desensitisation and increase tolerance to visual stimuli and to 
visuo-vestibular conflict.  Patients are therefore exposed, under the instruction of the 
vestibular physiotherapist, to optokinetic stimuli which can be delivered via projection 
screens, head mounted virtual reality systems, video monitors, ballroom 
planetariums or optokinetic rotating systems (22). Initially patients watch these 
stimuli whilst seated, then standing, walking, initially without and then with head 
movements, in a progressive fashion (Figure 3).  Research has shown that these 
patients benefit from repeated and gradual exposure to such visual motion training 
programs; both the dizziness and associated psychological symptoms improve over 
and above conventional vestibular rehabilitation (23).  
     Although no controlled trials for drug treatment of visual vertigo have been 
conducted, some evidence that Acetazolamide may be useful has been presented 
(24). As visual vertigo is prominent in patient with vestibular migraine, it could be 
argued that the Acetazolamide related improvement is due to its general 
antimigraine properties (25).  Finally, as visual vertigo may be a component of PPPD 
clinicians should assess whether additional counselling, psychotherapy or 
psychopharmacological treatment, in particular antidepressants, may be required (for 




     Susceptibility to motion sickness is ubiquitous and possessed by all individuals 
with intact vestibular function.  This proneness has become more problematic for 
more susceptible individuals in modern vehicular and visual environments. The 
primary signs and symptoms of motion sickness are nausea and vomiting.  Other 
commonly related symptoms include stomach awareness, sweating and facial pallor 
(so-called ‘cold sweating’), increased salivation, sensations of bodily warmth, 
dizziness, drowsiness, headache, loss of appetite and increased sensitivity to 
odours.  Motion sickness can be provoked by a wide range of situations - in cars, 
tilting trains, funfair rides, aircraft, weightlessness in outer-space, virtual reality and 
simulators.  The term ‘motion sickness’ embraces car-sickness, air-sickness, space-
sickness, sea-sickness, etc. (28).  The increasing use of new visual technologies 
such as virtual reality (29) and driverless autonomous vehicles (30) may increase the 
general public exposure to environments capable of provoking motion sickness.   
     Physiological responses associated with motion sickness vary between 
individuals.  For the stomach, gastric stasis occurs and increased frequency and 
reduced amplitude of the normal electro-gastric rhythm (31).  Other autonomic 
changes include sweating and vasoconstriction of the skin causing pallor (less 
commonly skin vasodilation and flushing in some individuals), with the simultaneous 
opposite effect of vasodilation and increased blood flow of deeper blood vessels, 
changes in heart rate which are often an initial increase followed by a rebound 
decrease, and inconsistent changes in blood pressure (28).  A whole host of 
hormones are released, mimicking a generalised stress response, amongst which 
vasopressin is thought to be most closely associated with the time course of motion 
sickness (32).  The observation of cold sweating suggests that motion sickness may 
disrupt aspects of temperature regulation (33), a notion consistent with the 
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observation that motion sickness reduces deep core body temperature during cold 
water immersion, accelerating onset of hypothermia (34). 
      Motion sickness is unpleasant but also under some circumstances it may have 
adverse consequences for performance and even survival.  Motion sickness 
preferentially causes decrements on performance of tasks which are complex, 
require sustained performance and offer the opportunity of the person to control the 
pace of their effort (35).  For pilots and aircrew it can slow training in the air and in 
simulators and even cause a minority to fail training altogether (28).  Approximately 
70% of novice astronauts will suffer space sickness in the first 24 hours of flight.  The 
possibility of vomiting while in a spacesuit in microgravity is potentially life 
threatening, consequently precluding extravehicular activity for the first 24 hours of 
spaceflight (36).   For survival-at-sea, such as in in life rafts, seasickness can reduce 
survival chances by a variety of mechanisms, including reduced morale and the ‘will 
to live’, failure to consistently perform routine survival tasks, dehydration due to loss 
of fluids through vomiting (28), and possibly due to the increased risk of hypothermia 
(34). 
Causes and Reasons for Motion Sickness  
     Any proposed mechanism for motion sickness must account for the observation 
that the physical intensity of the stimulus is not necessarily related to the degree of 
nauseogenicity.  Indeed with optokinetic (visual motion) stimuli there is no real 
motion.  A person sitting at the front in a wide screen cinema experiences self-
vection and ‘cinerama sickness’ but there is no physical motion of the body.  In this 
example, the vestibular and somatosensory systems are signalling that the person is 
sitting still, but the visual system is signalling illusory movement or self-vection.  
Consequently, the generally accepted explanation is based on some form of sensory 
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conflict or sensory mismatch.  The sensory conflict or sensory mismatch is between 
actual versus expected invariant patterns of vestibular, visual & kinaesthetic inputs 
(37).  Brainstem and cerebellar neurons whose activity corresponds to what might be 
expected of putative ‘sensory conflict’ neurons have been identified (38).  Benson 
(28) categorised neural mismatch into two main types: (i) conflict between visual and 
vestibular inputs or (ii) mismatch between the semicircular canals and the otoliths.  A 
simplified model was proposed by Bos and Bles (39) that there is only one conflict: 
between the subjective expected vertical and the sensed vertical.  However, despite 
this apparent simplification the underlying model is necessarily complex and finds 
difficulty in accounting for the observation that motion sickness can be induced by 
types of optokinetic stimuli which pose no conflict concerning the earth vertical (40). 
A useful set of rules was proposed by Stott (41), which if broken, will lead to motion 
sickness:   Rule 1.  Visual-vestibular: motion of the head in one direction must result 
in motion of the external visual scene in the opposite direction;   Rule 2. Canal-
otolith: rotation of the head, other than in the horizontal plane, must be accompanied 
by appropriate angular change in the direction of the gravity vector; Rule 3. Utricle-
saccule:  any sustained linear acceleration is due to gravity, has an intensity of 1 g 
and defines ‘downwards’.   In other words, the visual world should remain space 
stable, and gravity should always point down and average over a few seconds to 1 g.   
     The above describes what might be termed the ‘how’ of motion sickness in terms 
of mechanisms.  By contrast it is necessary to look elsewhere for an understanding 
of the ‘why’ of motion sickness.  Motion sickness itself could have evolved from a 
system designed to protect from potential ingestion of neurotoxins by inducing 
vomiting when unexpected central nervous system inputs are detected, the “toxin 
detector” theory  of Treisman (42). This system would be activated by modern 
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methods of transport that cause mismatch.  This theory is consistent with the 
observation that people who are more susceptible to motion sickness are also more 
susceptible to emetic toxins, chemotherapy sickness, and post-operative nausea and 
vomiting (PONV) (43).  In addition this theory has been experimentally tested with 
evidence of reduced emetic response to challenge from toxins after bilateral 
vestibular ablation (44). Less popular alternatives to the toxin detector hypothesis 
propose that motion sickness could be the result of aberrant activation of vestibular-
cardiovascular reflexes (45); or that it might originate from a warning system that 
evolved to discourage development of perceptual motor programmes that are 
inefficient or cause spatial disorientation (46); or that motion sickness is a 
unfortunate consequence of the physical proximity of the motion detector (vestibular) 
and vomiting circuitry in the brainstem (47). 
Individual differences in motion sickness susceptibility 
     Individuals vary widely in their susceptibility, and there is evidence from twin 
studies that a large proportion of this variation is accounted for by genetic factors 
with heritability estimates around 55-70% (48).  A large-scale genome study has 
isolated 35 single-nucleotide polymorphisms (SNPs) associated with motion 
sickness susceptibility, demonstrating that multiple genes are involved (49). Some 
groups of people have particular risk factors.  Infants and very young children are 
immune to motion sickness with motion sickness susceptibility beginning from 
around 6 to 7 years of age (37) and peaking around 9 to 10 years (50).  Following 
this peak susceptibility, there is a subsequent decline of susceptibility during the 
teenage years towards adulthood around 20 years.  This doubtless reflects 
habituation.    
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      Women appear somewhat more susceptible to motion sickness than men; 
women show higher incidences of vomiting and reporting a higher incidence of 
symptoms such as nausea (51).  This increased susceptibility is likely to be objective 
and not subjective because women vomit more than men; surveys of passengers at 
sea indicate a 5 to 3 female to male risk ratio for vomiting (52).   Although 
susceptibility varies over the menstrual cycle, peaking around menstruation, it is 
unlikely that this can fully account for the greater susceptibility in females because 
the magnitude of fluctuation in susceptibility across the cycle is only around one third 
of the overall difference between male and female susceptibility (53).  The elevated 
susceptibility of females to motion sickness or indeed to post-operative nausea and 
vomiting or chemotherapy induced nausea and vomiting (43, 54), may serve an 
evolutionary function.  Thus, more sensitive sickness thresholds in females may 
serve to prevent exposure of the foetus to harmful toxins during pregnancy.  
Individuals who have complete bilateral loss of labyrinthine (vestibular apparatus) 
function are largely immune to motion sickness.  However this may not be true under 
all circumstances since there is evidence that some bilateral labyrinthine defective 
individuals are still susceptible to motion sickness provoked by visual stimuli (visual 
vertigo) designed to induce self-vection during pseudo-Coriolis stimulation, i.e. 
pitching head movements in a rotating visual field (55).   
     Certain groups with medical conditions may be at elevated risk. Many patients 
with vestibular pathology and disease and vertigo can be especially sensitive to any 
type of motion.  The known association among migraine, motion sickness sensitivity, 
and Meniere’s disease dates back to the initial description of the syndrome by 
Prosper Meniere in 1861.  The reason for the elevated motion sickness susceptibility 
in migraineurs is not known but may be due to altered serotonergic system 
14 
 
functioning (56).  Patients with vestibular migraine are especially susceptible to 
motion sickness (57).   Motion sickness susceptibilities are shown for various 
vestibular disorders and migraine versus healthy controls (58) see Figure 4. 
     A rapid estimate of an individual’s susceptibility can be made using Motion 
sickness Susceptibility Questionnaires (sometimes called Motion History 
Questionnaires).  A typical questionnaire is shown in Table 1, which has been 
validated for exposure to motion stimuli in the laboratory and in transport 
environments (59). An overall indicator of susceptibility, may be calculated as the 
MSSQ score = (total sickness score) x (18) / (18 - number of motion types not 
experienced); this formula corrects for differing extent of exposure to different motion 
stimuli in individuals.  For the normal population, the median MSSQ score is 11.3, 
where higher scores indicate greater susceptibility and vice versa. 
Mal de Debarquement 
     Whittle (60) provided an early description of Mal de Debarquement  Syndrome 
(MdDS), after the landing and during the advance of the troops of William of Orange 
in Torbay in 1688. “As we marched here upon good Ground, the Souldiers would 
stumble and sometimes fall because of a dissiness in their Heads after they had 
been so long toss’d at Sea, the very Ground seem’d to rowl up and down for some 
days, according to the manner of the Waves’.  MdDS is the sensation of 
unsteadiness and tilting or rocking when a sailor returns to land.  A similar effect is 
observed in astronauts returning to 1 g on Earth after extended time in 
weightlessness in space.  This can lead to illusory motion as, if still on a boat, but, 
unlike motion sickness, there is little or no nausea.   MdDS symptoms usually 
resolve within a few hours as individuals readapt to the normal land environment.  
Individuals susceptible to MdDS may have reduced reliance on vestibular and visual 
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inputs and increased dependence on the somatosensory system for the 
maintenance of balance (61).  In a minority of individuals symptoms persist and can 
be troublesome.  Customised vestibular exercises have been proposed as a 
treatment (62). Some temporary relief can be obtained by re-exposure to motion but 
this is not a viable treatment.  Standard anti-motion sickness drugs appear 
ineffective but benzodiazepines appear to offer some relief (63).  Transcranial 
Magnetic Stimulation (TMS) is a potential treatment (64).  MdDS is discussed 
elsewhere in this issue. 
Behavioural countermeasures to reduce motion sickness. 
     Habituation offers the surest counter measure to motion sickness but by definition 
is a long-term approach. Habituation is superior to anti-motion sickness drugs, and it 
is free of side effects (65). The most extensive habituation programmes, often 
denoted “motion sickness desensitisation,” are run by the military with success rates 
exceeding 85% (28) but can be extremely time consuming, lasting many weeks.  
Critical features include: (a) the massing of stimuli (exposures at intervals greater 
than a week almost prevents habituation), (b) use of graded stimuli to enable faster 
recoveries and more sessions to be scheduled, which may help avoid the opposite 
process of sensitization, and (c) maintenance of a positive psychological attitude to 
therapy (66).  Sleep loss should be avoided since not only can it increase motion 
sickness sensitivity but more importantly impedes the rate of adaptation over 
successive motion exposures (67). 
     Habituation may be specific to a particular stimulus, for example tolerance to car 
travel may confer no protection to seasickness.  Anti-motion sickness drugs are of 
little use in this context, since both laboratory (68) and sea studies (69) show that 
although such medication may speed habituation compared to placebo in the short 
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term, in the longer term it is disadvantageous.  This is because when the anti-motion 
sickness medication is discontinued, the medicated group relapses and is worse off 
than those who were habituated under placebo.   
     Immediate short-term behavioural counter measures include reducing head 
movements, aligning the head and body with GIF, the gravito-inertial forces, (70, 71) 
or laying supine (72).  However, such protective postures may be incompatible with 
task performance.  It is usually better to be in control, i.e. to be the driver or pilot 
rather than a passenger (73).  Obtaining a stable external horizon reference is 
helpful (74).  Controlled regular breathing has been shown to provide increased 
motion tolerance, and may involve activation of the known inhibitory reflex between 
respiration and vomiting (66).  Supplemental oxygen may be effective for reducing 
motion sickness in patients during ambulance transport, but it is ineffective in healthy 
individuals, this apparent paradox being explained by the suggestion that 
supplemental oxygen may work by ameliorating a variety of internal states that 
sensitize for motion sickness rather than against motion sickness per se (75).   
     Some report acupuncture and acupressure to be effective against motion 
sickness (76) however other well controlled trials find no evidence for their value 
(77). High frequency head vibration can provide some reduction in motion sickness 
and a similar technique of noisy vestibular stimulation by vibration reduced visually 
induced motion sickness (VIMS), the effectiveness being best when time-coupled to 
periods of visual motion (78).  Although electrical stimulation of the vestibular 
apparatus, usually termed ‘galvanic vestibular stimulation’ (GVS) can cause vertigo 
and nausea, the opposite effect has been proposed, that it may provide a novel, 
countermeasure for motion sickness (78).   Similarly, galvanic cutaneous stimulation 
has been shown to reduce symptoms during driving simulation. Transcranial 
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electrical stimulation has been shown to reduce motion sickness evoked by physical 
motion and visual motion (78).  However the practicality of all of these vibratory and 
electrical stimulation techniques against motion sickness remains to be proven in the 
real world outside of the laboratory.    
    For habitual smokers acute withdrawal from nicotine provides significant 
protection against motion sickness (79).  Indeed this finding may explain why 
smokers are at reduced risk for postoperative nausea & vomiting (PONV) whereas 
non-smokers have elevated risk; the temporary nicotine withdrawal peri-operatively 
and consequent increased tolerance to sickness from any source may explain why 
smokers have reduced risk for PONV (79).  It has been suggested that ginger (main 
active agent gingerol) acts to calm gastrointestinal feedback, but studies of its effects 
on motion sickness have been equivocal making it an unlikely potent anti-motion 
sickness agent (80).  The findings for any effects of diet are contradictory. For 
example, a study suggesting that protein-rich meals may inhibit motion sickness (81) 
may be contrasted with a study which drew the opposite conclusion that any meal of 
high protein or dairy foods 3-6 h prior to flight should be avoided to reduce 
airsickness susceptibility (82).  
Pharmacological countermeasures 
     Drugs currently used against motion sickness may be divided into the categories:  
anti-muscarinics (e.g. scopolamine), H1 anti-histamines (e.g. dimenhydrinate), and 
sympathomimetics (e.g. amphetamine) and have improved little over 50 years (83).  
Commonly used anti-motion sickness drugs are shown in Table 2.   Other more 
recently developed anti-emetics are not effective against motion sickness, including 
D2 dopamine receptor antagonists, and 5HT3 antagonists used for side effects of 
chemotherapy, (84).  Nor do the neurokinin 1 antagonist anti-emetics appear 
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effective against motion sickness (85).  This is probably because their sites of action 
may be at vagal afferent receptors or the brainstem chemoreceptor trigger zone 
(CTZ), whereas anti-motion sickness drugs act elsewhere perhaps at the vestibular 
brainstem nuclei.   
     All anti-motion sickness drugs can produce unwanted side effects, drowsiness 
being the most common.  Promethazine is a classic example (65).  Scopolamine 
may cause blurred vision in a minority of individuals, especially with repeated dosing.  
The anti-motion sickness combination drug amphetamine+scopolamine (so-called 
“Scop-dex”) is probably the most effective with the fewest side-effects, at least for 
short-term use.  This is because both scopolamine and amphetamine are proven 
anti-motion sickness drugs, doubtless acting through different pathways so they 
have additive efficacy, and their side-effects of sedation and stimulation cancel each 
other out.  Unfortunately for legal reasons the Scop-dex combination is no longer 
available apart from specialised military use and alternative stimulants such as 
Modafinil seem ineffective (86).   
     Oral administration must anticipate motion since motion sickness induces gastric 
stasis consequently preventing drug absorption by this route (87).  Injection 
overcomes the various problems of slow absorption kinetics and gastric stasis or 
vomiting.  Other routes such as transdermal also offer advantages providing 
protection for up to 72 hours with low constant concentration levels in blood, thus 
reducing side effects. However, transdermal scopolamine (Table 2) has a very slow 
onset time (6-8 h), which be offset by simultaneous administration of oral 
scopolamine enabling protection from 30 minutes onwards (88).  There may be 
variability in absorption via the transdermal route which alters effectiveness between 
individuals (89).  Buccal absorption is effective with scopolamine but an even faster 
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route is via nasal scopolamine spray.  Peak blood levels via the nasal route may be 
achieved in 10 minutes and this has been shown to be effective against motion 
sickness (90).  
     Investigations of new anti-motion sickness drugs include re-examination of old 
drugs such as phenytoin, as well as the development of new agents. The range of 
drugs is wide and the list is long.  Such drugs include phenytoin, betahistine, 
chlorpheniramine, cetirizine, fexofenadine, benzodiazepines and  barbiturates, the 
anti-psychotic droperidol, corticosteroids such as dexamethasone, tamoxifen, opioids 
such as the u-opiate receptor agonist loperamide, neurokinin NK1 receptor 
antagonists, vasopressin V1a receptor antagonists, NMDA antagonists, 3-
hydroxypyridine derivatives, 5HT1a receptor agonists such as the anti-migraine 
triptan rizatriptan, ghrelin agonists, selective muscarinic M3/m5 receptor antagonists 
such as zamifenacin and darifenacin.  So far none of these drugs have proven to be 
of any major advantage over those currently available for motion sickness (91).  The 
reasons are various and include relative lack of efficacy, complex and variable 
pharmacokinetics, or in those that are effective, unacceptable side-effects.  Future 
development of drugs with highly selective affinities to receptor subtypes relevant to 
motion sickness may produce an anti-motion sickness drug of high efficacy with few 
side-effects.  A good candidate would be a selective antagonist for the m5 
muscarinic receptor (92).  
Motorists’ (vestibular) disorientation 
     Motorists’ disorientation. Motorists learn to interpret sensory stimuli in the context 
of the car stabilised by its suspension and guided by steering. However, the sensory 
stimulation during driving is potentially ambiguous: the forces of cornering may be 
interpreted as tilt rather than as lateral acceleration and visual flow of the road and 
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traffic can be interpreted to indicate veering, a form of ‘visual vertigo’. There is no 
consistent pattern of co-morbidity but subjects with vestibular or other sensory 
disturbances, anxiety or phobia may be more susceptible. Once developed, it is 
difficult to suppress the tendency to disorientation when driving.  
Spatial disorientation while driving 
     Many readers will have some experience of spatial disorientation in road vehicles 
for which the underlying causes are almost always identifiable within the known 
physiology of spatial orientation. Common manifestations are as follows. A more 
detailed analysis is given in Golding and Gresty (78).   
     The very steep hill: the perception of extreme inclination is an illusion since the 
steepest metaled roads in Europe involve only 18–20° of tilt above horizontal. The 
appearance of gradient derives from visual foreshortening, engine load, 
misperception of subjective tilt due to seated posture, and redistribution of blood 
volume from the legs to the trunk (93).  
     The tilted horizon: the horizon may appear to be tilted when driving caused by 
both a visual ‘frame effect’ of the road and scenery giving false cues to orientation 
and also by ocular counter-rolling. The counter-rolling is provoked by the lateral 
acceleration rounding a bend evoking otolith-ocular reflexes. Lateral acceleration, 
say to the right evokes ocular counter-rolling to the left which induces an apparent 
rightwards tilt of the visual world. Illusions of horizon tilt could induce the perception 
of rolling over in vehicles (94,95) and may be part of the mechanism, evoked later in 
the chapter, explaining serious, persistent disorientation.  
     Apparent drift when stationary: this is a version of the “railway illusion” of self-
motion in a stationary carriage provoked by the sight of an adjacent train moving. 
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Illusory drift in a vehicle is often provoked when vehicles moving on either side of 
one’s own stationary vehicle induce ‘vection’ (cf ‘visual vertigo’, above).  
     Tilting and rolling over: a perception of rolling over without actual rotation from 
vertical is associated with lateral linear acceleration and with rolling of the visual 
scene (94,95). The lateral, ‘centripetal’, acceleration experienced when rounding a 
bend causes a tilt of the gravitoinertial vertical from earth upright in the direction of 
the centre of rotation. This earth tilted direction of the Gravito Inertial Forces acting 
on the car is ‘physical uprightness’: witness the cyclist who leans into the bend to 
balance his bike. However, the weight and suspension of a four-wheeled vehicle 
keeps it oriented approximately earth upright. A driver learns to interpret the 
centripetal acceleration of cornering as a lateral force on his flank but an alternative 
perception, which is feasible in physics, is that the driver is tilted out of the bend 
away from the gravitoinertial upright which occurs as a compelling disorientation. 
This mis-perception is perhaps facilitated by the lack of structure on open highways, 
masking vibration and noise and banking of the road. 
     Veering: feeling that the car is threatening to veer to the side of the road occurs 
typically on open fast roads. A perception veering is a form of vection (cf ‘visual 
vertigo’ above) and is probably provoked by the ‘optokinetic’ stimulation of visual flow 
which induces a sense of self-motion in the opposite direction to the flow which is 
some combination of rotation and linear translation. On an open straight highway the 
dominant rapid optic flow is from the view of the proximal road and roadside whereas 
optic flow of the distance is of lower angular velocity and not so compelling. A 
possible perception induced in the driver is of a rotation away from the origin of the 
visual flow which is interpreted as veering. Veering may also occur when traffic such 
as large trucks are passing by, or vehicles are entering towards the driver from a slip 
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road. The visual flow of the passing traffic can induce the perception of motion in the 
opposite direction, which a potential trajectory into that traffic.  Susceptibility to 
vection may be enhanced because somatosensory cues to orientation may be 
masked by vibration, downregulated because of monotony and adapted because of 
immobility of the seated driver.  
     Such disorientation accords with an inappropriate interpretation of the sensory 
signals that arise from a complex, dynamic environment (96) and can be thought of 
as a naïve way of interpreting sensory signals, whereas driving is a highly cognitive 
skill (97) demanding specific selection and interpretation of sensory input. The driver 
may not be aware of disorientation and may respond to subliminal cues (98) so that 
steering adjustments can occur before perception of veering. 
Motorists complaining of systematic disorientation ‘Dizzy Drivers’ 
     Occasional drivers present with complaints of inappropriate perceptions of 
veering and tilt or rolling over on the highway. These are the dominant features of 
the ‘motorist’s vestibular disorientation syndrome’ as first described by Page and 
Gresty (16), but better termed ‘motorists disorientation syndrome’ (99). The 
inappropriate perceptions are so systematic that patients have changed cars before 
realizing that the problem was not that of the vehicle. In some patients the onset of 
disorientation symptoms is abrupt in a single experience; in others there seems to be 
a gradual buildup of severity of symptoms until threat of veering or rolling over 
become a reliable occurrence on all open highways, thereby confining the driver to 
lesser town and suburban roads.  
     It is commonplace for passengers to become apprehensive that a vehicle is 
running out of control, often expressed in the ‘back seat driver’ attitude. The striking 
feature of motorist’s disorientation is that the driver, used to being in control, is 
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surprised that he perceives the vehicle to be unstable under unremarkable road 
conditions.   
     Susceptibility to disorientation was originally thought to be caused by vestibular 
imbalance (16). It is certainly the case that vestibular disorder causes incorrect 
orientation in a vehicle (100,101,102). However, subsequent experience showed that 
few dizzy drivers have identifiable vestibular asymmetry. Almost all have no related 
organic disorder although many have trait or state anxiety.  The following patients 
are illustrative with further details given in Golding and Gresty (78). In all patients to 
be described the stereotypical characteristics of disorientation were rolling over 
and/or veering. 
1) A middle aged man experienced symptoms of disorientation when driving 
which completely disappeared when a hitherto unsuspected ‘BPPV’ (benign 
paroxysmal positional vertigo) was identified and resolved by an Epley manoeuvre. 
2) After a near crash flying in fog a special forces pilot experienced 
perceptions of instability in his helicopter which extended to driving his car. He was 
in a divorce but denied that he was otherwise stressed by operations that had killed 
a colleague. 
3) A middle age man, retraining after an unsuccessful career, began to 
experience disorientation driving on the highway to a retraining centre. He admitted 
to considerable anxiety about security and achievement.  
4) Two taxi drivers and one roadside assistance mechanic, all had similar 
abrupt onset of persistent disorientation when highway driving. One was provoked 
crossing a high bridge, a second when exiting a roundabout causing her steer into 
oncoming traffic. None had identifiable organic disorder or raised anxiety.  
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4) When deserted by her husband, a mother with several children began to 
experience disorientation, even on local roads, when driving to work and trying to 
manage child care. 
Prevalence 
     In a London tertiary referral clinic, specializing in and balance disorders (A. M. 
Bronstein, personal observation), 4–5 patients per year are seen with specific 
complaints of driving, amongst 450–500 new patients referred with complaints of 
dizziness. The sufferers have been adults of both sexes, and rarely with a history of 
psychiatric or relevant organic disorder. 
     The absence of comprehensive surveys of ‘dizzy motorists’ in the medical 
literature, following the original study is surprising since a recent article in a weekly 
magazine, aimed at housewives indicates a general awareness of the problem. 
Thus: Tanya Byron, writing in ‘Good Housekeeping’ (October 2018 pp 98-99) 
advises on ‘….fear of motorway driving’, highlighting the role of anxiety and phobia. 
She advises an otological screen for vestibular disorder and recommends 
appropriate cognitive behaviour therapy. The widespread awareness of motorists’ 
disorientation, despite the paucity of scientific literature may be because of sufferers’ 
fail to seek medical opinion for fear of disqualification from driving.   
Treatment 
     The treatment model for rehabilitation of motorists’ disorientation is based on 
rehabilitation of flying disorientation and motion sickness (103,104) and comprises 
desensitization and retraining within framework of cognitive therapy: viz 
• Exclusion of neurological/vestibular/psychiatric disorder and treatment of high 
anxiety. 
• Explanation of how disorientation may occur as described above. 
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• Progressive desensitization commencing with short duration exposures driving 
slowly on local roads progressing to faster trips on the highway. The protagonist 
gives himself a verbal briefing of the planned journey, talks himself through the 
driving manoeuvres and stopping for ‘time out’ if he becomes overstressed, in 
which case anxiolytic controlled breathing and postural relaxation may help. The 
verbal appraisal highlights cognitive context. For examples: if he feels his lane is 
too narrow a check that the vehicle ahead negotiates the lane with ease assures 
the driver that he can follow; if he feels veering he checks the steering wheel and 
sides of the vehicle against lane markings.  
• A log should be kept of the rehabilitation as reinforcing evidence of progress. 
     Desensitization by ‘immersion’ is inappropriate; a patient who persisted with long 
driving sessions on a therapist’s recommendation incurred a serious RTI road traffic 
incident which she attributed to accumulating disorientation. Patients who have 
complied with this therapeutic program have recovered the ability to drive but can 
readily decompensate.  However it seems that once a motorist has experienced 
disorientation it becomes difficult to “quarantine” (105) inappropriate interpretations 
of the sensory stimulation during driving and he may readily revert to disorientation. 
Implications for road safety 
     The authors have encountered only one serious accident resulting from a case of 
motorist’s disorientation together with one report of veering creating a potential for 
collision. It is likely that few incidents are reported because disorientation is so 
alarming that the driver slows or stops. Currently, there are no specific guidelines on 
fitness to drive while susceptible to motorists’ disorientation, although the advisability 
of both flying and driving with active BPPV, in which head tilts can provoke disabling 
dizziness, has been raised (101). 
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     In the road safety literature a high proportion of road traffic incidents are attributed 
to lapses of attention without adequate consideration of the role of spatial orientation. 
It should be stressed that a main factor in tuning attention and regulating vigilance is 
state of spatial orientation: viz driving fast on a highway may be unremarkable 
whereas viewing nearby, fast traffic from the roadside is alarming (78). 
Classification and relationship to other disorientation syndromes 
     Motorist’s disorientation has been classified with (14,106) ‘Phobic Postural Vertigo’ and 
more recently ‘Persistent Postural Dizziness’ (17, 107) which is a functional ‘vestibular 
system’ disorder. However, phobia is not typical of the majority of cases, as neither is 
contextual postural vertigo. Furthermore, some patients have a structural vestibular disorder 
which can account for misperceptions of orientation. Hence, such vague classifications are 
not helpful, particularly since the stereotypical symptoms of disoriented motorists can be 
explained by known physiological mechanisms. The missing element in understanding 
motorists’ disorientation is the precise mechanism causing the driver to abandon the learned 
framework of sensory interpretation during driving and adopt an alternative interpretation of 
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Figure 1:  When a passenger looks out of a bus fixating upon a road sign, vestibular 
(VOR) and visual (pursuit) mechanisms cooperate to stabilise the eyes on the visual 
target as the bus turns round.  In contrast, when a passenger tries to read a 
newspaper, the VOR takes the eyes off the visual target but pursuit eye movements 
suppress the VOR so that reading can proceed.  In the latter situation visual and 








Figure 2:  Horizontal electro-oculography in a patient 7 days (top) and one month 
after a labyrinthectomy (bottom).  The nystagmus in the acute phase is almost 
exclusively seen in the dark.  Such suppression of the nystagmus by visual fixation is 






Figure 3:  Optokinetic or visual motion desensitisation treatment for patients with 
vestibular disorders reporting visual vertigo symptoms.  Left:  roll (coronal) plane 
rotating optokinetic disk; Middle: planetarium-generated moving dots whilst the 
subject walks; Right:  ‘Eye-Trek’ or head-mounted TV systems projecting visual 
motion stimuli.  In this case, in advanced stages of the therapy, the patient moves 









Figure 4:  Motion sickness susceptibility is shown for patient groups after the onset of 
disease together with significances of comparison with age equivalent healthy 
controls.  Higher scores indicate greater motion sickness susceptibility. The 95%CIs 
are smaller for controls and Meniere’s disease as a consequence of larger numbers. 
BVL: bilateral vestibular loss; UVL: unilateral vestibular loss in compensated 
(adapted) patients; BPPV: benign paroxysmal positional vertigo.  BVL: bilateral 
vestibular loss; UVL: unilateral vestibular loss; BPPV: benign paroxysmal positional 
vertigo; Clin. Migraine: patients with severe migraine attending migraine clinics   





Table 1:  Motion Sickness Susceptibility Questionnaire Short-form (MSSQ-Short) 
(adapted from Golding 2006 [59]) 
This questionnaire is designed to find out how susceptible to motion sickness you are, and what sorts 
of motion are most effective in causing that sickness.  Sickness here means feeling queasy or 
nauseated or actually vomiting.  
 
Your CHILDHOOD Experience Only (before 12 years of age), for each of the following types of 
transport or entertainment please indicate: 
 














Cars       
Buses or Coaches      
Trains      
Aircraft      
Small Boats      
Ships, e.g. Channel Ferries      
Swings in playgrounds      
Roundabouts in playgrounds      
Big Dippers, Funfair Rides      
     t  0  1  2                    3
  
Your Experience over the LAST 10 YEARS (approximately), for each of the following types of 





2. Over the LAST 10 YEARS, how often you Felt Sick or Nauseated (tick boxes): 
 
 Not Applicable  









Cars       
Buses or Coaches      
Trains      
Aircraft      
Small Boats      
Ships, e.g. Channel Ferries      
Swings in playgrounds      
Roundabouts in playgrounds      
Big Dippers, Funfair Rides      




Table 2:  Common Anti–Motion Sickness Drugs (Adapted from Benson, 2002 [28]) 
 
 
Drug    Route    Adult Dose   Time        Duration 
of Onset         of Action (h) 
____________________________________________________________________________ 
Scopolamine   oral    0.3–0.6 mg   30 min    4 
Scopolamine   injection   0.1–0.2 mg   15 min   4 
Scopolamine  transdermal patch one   6–8 h  72  
Promethazine   oral    25–50 mg   2 h   15 
Promethazine   injection   25 mg    15 min   15 
Promethazine   suppository   25 mg    1 h   15 
Dimenhydrinate  oral    50–100 mg  2 h     8 
Dimenhydrinate  injection   50 mg    15 min     8 
Cyclizine  oral    50 mg    2 h     6 
Cyclizine  injection   50 mg    15 min     6 
Meclizine   oral    25–50 mg   2 h     8 
Buclizine  oral    50 mg    1 h     6 
Cinnarizine  oral    15–30 mg  4 h     8 
____________________________________________________________________________ 
 
 
 
